News/ News/ R&D Handover of senior R&D roles at Merck continues, as Roy Baynes exits Phil Taylor appointment, Eikon Therapeutics, Merck & Co, R&D, Roger Perlmutter, Roy Baynes, senior management 0 Comment Merck & Co’s chief medical officer and head of clinical development Dr Roy Baynes has announced his retirement Share X Handover of senior R&D roles at Merck continues, as Roy Baynes exits https://pharmaphorum.com/news/handover-of-senior-rd-roles-at-merck-continues-as-roy-baynes-exits/